Key result
Multielectrode middle cardiac vein mapping identifies ~73% of deep VT circuits with low recurrence.
Why the study?
Does middle cardiac vein mapping using multielectrode catheters safely guide ablation and identify epicardial or intramural circuits in patients with structural heart disease and scar-related ventricular tachycardia?
Observational (n=33)
Does middle cardiac vein mapping using multielectrode catheters safely guide ablation and identify epicardial or intramural circuits in patients with structural heart disease and scar-related ventricular tachycardia?
Middle cardiac vein mapping with multielectrode catheters is a safe technique that helps identify epicardial and intramural VT circuits to guide targeted ablation strategies in patients with structural heart disease.
Answers are grounded in this paper and cite their sources.
Multielectrode MCV mapping appears feasible for scar-related VT; leaves open prospective validation of safety and long-term outcomes.
The coronary venous system offers an alternative route for mapping and ablation of ventricular arrhythmias, especially in presence of epicardial or intramural substrate. To investigate the feasibility, diagnostic yield and outcomes of middle cardiac vein (MCV) mapping using multielectrode catheters to guide ablation of scar-related ventricular tachycardia (VT). We included patients with structural heart disease and VT undergoing ablation in which MCV mapping was performed using multielectrode catheters. Left ventricular (LV) and/or right ventricular (RV) endocardial mapping was performed depending on the VT morphology, and the ablation strategy was selected based on endocardial and MCV activation in addition to pace mapping and/or entrainment. Thirty-three patients (60.5±13.6 years, 73% nonischemic) were included. VT was inducible in 97% of patients, with a median of 4 VT morphologies per patient. MCV and endocardial mapping suggested an epicardial circuit in 21 patients and epicardial access was obtained in 13 of them (percutaneous approach in 11 and surgical window in 2). Additionally, mapping was consistent with an intramural circuit in 3 patients, which were treated with sequential RF ablation from LV and RV (n = 3) and ethanol ablation (n = 2). There were no complications related to MCV mapping. Over a median follow-up of 13 months, 8 patients (24%) had VT recurrence. MCV mapping with multielectrode catheters is safe and facilitates identification of epicardial or intramural VT circuits, guides the need for epicardial access and provides an opportunity for therapeutic interventions such as venous RF delivery or ethanol infusion.
No takes yet. Share an insight, caveat, or question.
Gad et al. (2026) conducted an observational in Scar-related ventricular tachycardia in structural heart disease (n=33). Middle cardiac vein (MCV) mapping using multielectrode catheters was evaluated on VT recurrence. Middle cardiac vein mapping with multielectrode catheters identified epicardial or intramural VT circuits in 73% (24/33) of patients with 0% mapping complications and 24% VT recurrence at 13 months.
Synapse has enriched 10 related papers. Consider them for comparative context: